204 related articles for article (PubMed ID: 36063148)
21. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
[TBL] [Abstract][Full Text] [Related]
22. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
Zhang Q; Yang Z; Karamchandani DM
Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
[TBL] [Abstract][Full Text] [Related]
23. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy after prophylactic total gastrectomy.
Kaurah P; Fitzgerald R; Dwerryhouse S; Huntsman DG
Fam Cancer; 2010 Sep; 9(3):331-4. PubMed ID: 20063069
[TBL] [Abstract][Full Text] [Related]
25. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.
Lynch HT; Kaurah P; Wirtzfeld D; Rubinstein WS; Weissman S; Lynch JF; Grady W; Wiyrick S; Senz J; Huntsman DG
Cancer; 2008 Jun; 112(12):2655-63. PubMed ID: 18442100
[TBL] [Abstract][Full Text] [Related]
26. Controversies and strengths in prophylactic total gastrectomy for germline CDH1 pathogenic variant carriers.
Davis JL; Strong VE
Eur J Cancer Prev; 2023 Jul; 32(4):308-309. PubMed ID: 37038999
[No Abstract] [Full Text] [Related]
27. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
[TBL] [Abstract][Full Text] [Related]
28. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
[TBL] [Abstract][Full Text] [Related]
30. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
[TBL] [Abstract][Full Text] [Related]
31. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
32. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P; Humar B; Blair V
Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
[TBL] [Abstract][Full Text] [Related]
33. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
[TBL] [Abstract][Full Text] [Related]
34. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
[TBL] [Abstract][Full Text] [Related]
36. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
[TBL] [Abstract][Full Text] [Related]
38. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
39. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
[TBL] [Abstract][Full Text] [Related]
40. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]